Asthma management guidelines
Draft report of the National Heart, Lung and Blood Institute's National Asthma Education Program Coordinating Committee recommends that asthma patients receive cromolyn or a topical steroid, as well as a bronchodilator, during initial treatment. Committee member Albert Sheffer, MD, Harvard Medical School, presented an overview of the draft report at a June 8 meeting of the committee. Noting that there are "better topical steroids on the continent" than in the U.S., Sheffer decried the "steroid phobia" in the U.S. The final report on asthma management is to be completed by Nov. 2.
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.